Letter: can persisting liver stiffness indicate increased risk of HCC, after successful anti-HCV therapy?

T Karlas¹, J Benckert², S Beer¹, V Keim¹, T Berg², J Wiegand^{3

4}

Affiliations

¹ Unit of Interdisciplinary Ultrasound, University of Leipzig, Leipzig, Germany.
² Section of Hepatology, University of Leipzig, Leipzig, Germany.
³ Unit of Interdisciplinary Ultrasound, University of Leipzig, Leipzig, Germany. johannes.wiegand@medizin.uni-leipzig.de.
⁴ Section of Hepatology, University of Leipzig, Leipzig, Germany. johannes.wiegand@medizin.uni-leipzig.de.

PMID: 26753820
DOI: 10.1111/apt.13479

Comment

Letter: can persisting liver stiffness indicate increased risk of HCC, after successful anti-HCV therapy?

T Karlas et al. Aliment Pharmacol Ther. 2016 Feb.

. 2016 Feb;43(4):543-4.

doi: 10.1111/apt.13479.

Authors

T Karlas¹, J Benckert², S Beer¹, V Keim¹, T Berg², J Wiegand^{3

4}

Affiliations

¹ Unit of Interdisciplinary Ultrasound, University of Leipzig, Leipzig, Germany.
² Section of Hepatology, University of Leipzig, Leipzig, Germany.
³ Unit of Interdisciplinary Ultrasound, University of Leipzig, Leipzig, Germany. johannes.wiegand@medizin.uni-leipzig.de.
⁴ Section of Hepatology, University of Leipzig, Leipzig, Germany. johannes.wiegand@medizin.uni-leipzig.de.

PMID: 26753820
DOI: 10.1111/apt.13479

No abstract available

PubMed Disclaimer

Comment in

Letter: can persisting liver stiffness indicate increased risk for HCC, after successful anti-HCV therapy? - authors' reply.
Mandorfer M, Kozbial K, Peck-Radosavljevic M, Ferenci P. Mandorfer M, et al. Aliment Pharmacol Ther. 2016 Feb;43(4):544-5. doi: 10.1111/apt.13494. Aliment Pharmacol Ther. 2016. PMID: 26753821 No abstract available.
Letter: can persisting liver stiffness indicate increased risk of hepatocellular cell carcinoma after successful anti-HCV therapy? - authors' reply.
Deterding K, Schlevogt B, Port K, Cornberg M, Wedemeyer H. Deterding K, et al. Aliment Pharmacol Ther. 2016 Feb;43(4):546-7. doi: 10.1111/apt.13499. Aliment Pharmacol Ther. 2016. PMID: 26753822 No abstract available.

Comment on

Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.
Mandorfer M, Kozbial K, Freissmuth C, Schwabl P, Stättermayer AF, Reiberger T, Beinhardt S, Schwarzer R, Trauner M, Ferlitsch A, Hofer H, Peck-Radosavljevic M, Ferenci P. Mandorfer M, et al. Aliment Pharmacol Ther. 2015 Sep;42(6):707-18. doi: 10.1111/apt.13315. Epub 2015 Jul 16. Aliment Pharmacol Ther. 2015. PMID: 26179884
Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies.
Deterding K, Höner Zu Siederdissen C, Port K, Solbach P, Sollik L, Kirschner J, Mix C, Cornberg J, Worzala D, Mix H, Manns MP, Cornberg M, Wedemeyer H. Deterding K, et al. Aliment Pharmacol Ther. 2015 Oct;42(7):889-901. doi: 10.1111/apt.13343. Epub 2015 Aug 6. Aliment Pharmacol Ther. 2015. PMID: 26250762

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Letter: can persisting liver stiffness indicate increased risk of HCC, after successful anti-HCV therapy?

Affiliations

Letter: can persisting liver stiffness indicate increased risk of HCC, after successful anti-HCV therapy?

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical